A recommendation for high-dose Ara-C interval treatment based on studies in a slow-growing leukemia model (BNML).
D000818:Animals; D003561:Cytarabine / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D007942:Leukemia, Experimental / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D051381:Rats
D003561:Cytarabine